📊 Adding NTD specific funding by product

[spoonerf]

No description provided.

[owidbot]

Quick links (staging server):

Site	Admin	Wizard

Login: ssh owid@staging-site-ntd-funding-fix

chart-diff: ✅

• 1 new charts (1 approved)
• 0 modified charts (0 approved)

data-diff: ❌ Found differences

~ Dataset garden/neglected_tropical_diseases/2024-05-18/funding
-   -   The data collected in this survey has been used to create a unique repository of investment data, providing an unmatched resource for policy-makers, donors, researchers and industry. The database outlines the long-term landscape of funding for R&D for global health priority areas, including where funding gaps exist and how single investments fit into the global picture.
+   +   The data collected in this survey has been used to create a unique repository of investment data, providing an unmatched resource for policy-makers, donors, researchers and industry. The database outlines the long-term landscape of funding for R&D for global health priority areas, including where funding gaps exist and how single investments fit into the global picture. This dataset covers the majority of neglected disease, emerging infectious disease, and sexual & reproductive health R&D funding is captured by G-FINDER, because large funders active in this area and target groups identified by our Advisory Committee are typically responsive and, where they are not, are prioritised during survey follow-up.
+   + 
+   +   The dataset covers  major funding for: Neglected Diseases: Bacterial pneumonia & meningitis, Buruli ulcer, Chagas disease, Cryptococcal meningitis, Dengue, Diarrhoeal diseases, Helminth infections (worms & flukes), Hepatitis B, Hepatitis C, Histoplasmosis, HIV/AIDS, Kinetoplastid diseases, Leprosy, Leptospirosis, Malaria, Mycetoma, Rheumatic fever, Salmonella infections, Scabies, Snakebite envenoming, Trachoma, Tuberculosis, Yaws. Emerging Infectious Diseases: Arenaviral haemorrhagic fevers (including Lassa fever), Bunyaviral diseases (including CCHF, RVF, SFTS), Chikungunya, Coronaviral diseases (including MERS, SARS, COVID-19), Emergent non-polio enteroviruses (including EV71, D68), Filoviral diseases (including Ebola, Marburg), Henipaviral diseases (including Nipah), Mpox (monkeypox), Zika. Sexual & Reproductive Health: Contraception, HIV/AIDS, HPV and HPV-related cervical cancer, Multi-purpose prevention technologies, Post-partum haemorrhage, Pre-eclampsia and eclampsia, Sexually transmitted infections.
  = Table funding_disease
    ~ Dim country
+       + New values: 16 / 1025 (1.56%)
           year             disease country
           2008 Malaria - all types   World
           2013 Malaria - all types   World
           2015 Malaria - all types   World
           2016 Malaria - all types   World
           2020 Malaria - all types   World
    ~ Dim year
+       + New values: 16 / 1025 (1.56%)
          country             disease  year
            World Malaria - all types  2008
            World Malaria - all types  2013
            World Malaria - all types  2015
            World Malaria - all types  2016
            World Malaria - all types  2020
    ~ Dim disease
+       + New values: 16 / 1025 (1.56%)
          country  year             disease
            World  2008 Malaria - all types
            World  2013 Malaria - all types
            World  2015 Malaria - all types
            World  2016 Malaria - all types
            World  2020 Malaria - all types
    ~ Column amount__usd (changed metadata, new data)
-       - title: Funding for << disease.lower() >>, all technologies
        ?                                         ^
+       + title: Funding for << disease.lower() >> - all technologies
        ?                                         ^^
-       -       The data collected in this survey has been used to create a unique repository of investment data, providing an unmatched resource for policy-makers, donors, researchers and industry. The database outlines the long-term landscape of funding for R&D for global health priority areas, including where funding gaps exist and how single investments fit into the global picture.
-       -     title_snapshot: G-FINDER -  Neglected Diseases
+       +       The data collected in this survey has been used to create a unique repository of investment data, providing an unmatched resource for policy-makers, donors, researchers and industry. The database outlines the long-term landscape of funding for R&D for global health priority areas, including where funding gaps exist and how single investments fit into the global picture. This dataset covers the majority of neglected disease, emerging infectious disease, and sexual & reproductive health R&D funding is captured by G-FINDER, because large funders active in this area and target groups identified by our Advisory Committee are typically responsive and, where they are not, are prioritised during survey follow-up.
+       + 
+       +       The dataset covers  major funding for: Neglected Diseases: Bacterial pneumonia & meningitis, Buruli ulcer, Chagas disease, Cryptococcal meningitis, Dengue, Diarrhoeal diseases, Helminth infections (worms & flukes), Hepatitis B, Hepatitis C, Histoplasmosis, HIV/AIDS, Kinetoplastid diseases, Leprosy, Leptospirosis, Malaria, Mycetoma, Rheumatic fever, Salmonella infections, Scabies, Snakebite envenoming, Trachoma, Tuberculosis, Yaws. Emerging Infectious Diseases: Arenaviral haemorrhagic fevers (including Lassa fever), Bunyaviral diseases (including CCHF, RVF, SFTS), Chikungunya, Coronaviral diseases (including MERS, SARS, COVID-19), Emergent non-polio enteroviruses (including EV71, D68), Filoviral diseases (including Ebola, Marburg), Henipaviral diseases (including Nipah), Mpox (monkeypox), Zika. Sexual & Reproductive Health: Contraception, HIV/AIDS, HPV and HPV-related cervical cancer, Multi-purpose prevention technologies, Post-partum haemorrhage, Pre-eclampsia and eclampsia, Sexually transmitted infections.
+       +     title_snapshot: G-FINDER

+       + New values: 16 / 1025 (1.56%)
          country  year             disease  amount__usd
            World  2008 Malaria - all types  682608384.0
            World  2013 Malaria - all types  631369280.0
            World  2015 Malaria - all types  665889984.0
            World  2016 Malaria - all types  692839296.0
            World  2020 Malaria - all types  696215552.0
  = Table funding_product
    ~ Column amount__usd (changed metadata)
-       - title: Funding for technology - << product.lower() >>
+       + title: Funding for technology - << product.lower() >> - towards all diseases
        ?                                                      +++++++++++++++++++++++
-       -       The data collected in this survey has been used to create a unique repository of investment data, providing an unmatched resource for policy-makers, donors, researchers and industry. The database outlines the long-term landscape of funding for R&D for global health priority areas, including where funding gaps exist and how single investments fit into the global picture.
-       -     title_snapshot: G-FINDER -  Neglected Diseases
+       +       The data collected in this survey has been used to create a unique repository of investment data, providing an unmatched resource for policy-makers, donors, researchers and industry. The database outlines the long-term landscape of funding for R&D for global health priority areas, including where funding gaps exist and how single investments fit into the global picture. This dataset covers the majority of neglected disease, emerging infectious disease, and sexual & reproductive health R&D funding is captured by G-FINDER, because large funders active in this area and target groups identified by our Advisory Committee are typically responsive and, where they are not, are prioritised during survey follow-up.
+       + 
+       +       The dataset covers  major funding for: Neglected Diseases: Bacterial pneumonia & meningitis, Buruli ulcer, Chagas disease, Cryptococcal meningitis, Dengue, Diarrhoeal diseases, Helminth infections (worms & flukes), Hepatitis B, Hepatitis C, Histoplasmosis, HIV/AIDS, Kinetoplastid diseases, Leprosy, Leptospirosis, Malaria, Mycetoma, Rheumatic fever, Salmonella infections, Scabies, Snakebite envenoming, Trachoma, Tuberculosis, Yaws. Emerging Infectious Diseases: Arenaviral haemorrhagic fevers (including Lassa fever), Bunyaviral diseases (including CCHF, RVF, SFTS), Chikungunya, Coronaviral diseases (including MERS, SARS, COVID-19), Emergent non-polio enteroviruses (including EV71, D68), Filoviral diseases (including Ebola, Marburg), Henipaviral diseases (including Nipah), Mpox (monkeypox), Zika. Sexual & Reproductive Health: Contraception, HIV/AIDS, HPV and HPV-related cervical cancer, Multi-purpose prevention technologies, Post-partum haemorrhage, Pre-eclampsia and eclampsia, Sexually transmitted infections.
+       +     title_snapshot: G-FINDER
  = Table funding_disease_product
    ~ Dim country
+       + New values: 101 / 3773 (2.68%)
           year             disease                              product country
           2007 Malaria - all types                                Drugs   World
           2011 Malaria - all types                                Drugs   World
           2016 Malaria - all types Diagnostics and diagnostic platforms   World
           2019 Malaria - all types Diagnostics and diagnostic platforms   World
           2020 Malaria - all types Vector control products and research   World
    ~ Dim year
+       + New values: 101 / 3773 (2.68%)
          country             disease                              product  year
            World Malaria - all types                                Drugs  2007
            World Malaria - all types                                Drugs  2011
            World Malaria - all types Diagnostics and diagnostic platforms  2016
            World Malaria - all types Diagnostics and diagnostic platforms  2019
            World Malaria - all types Vector control products and research  2020
    ~ Dim disease
+       + New values: 101 / 3773 (2.68%)
          country  year                              product             disease
            World  2007                                Drugs Malaria - all types
            World  2011                                Drugs Malaria - all types
            World  2016 Diagnostics and diagnostic platforms Malaria - all types
            World  2019 Diagnostics and diagnostic platforms Malaria - all types
            World  2020 Vector control products and research Malaria - all types
    ~ Dim product
+       + New values: 101 / 3773 (2.68%)
          country  year             disease                              product
            World  2007 Malaria - all types                                Drugs
            World  2011 Malaria - all types                                Drugs
            World  2016 Malaria - all types Diagnostics and diagnostic platforms
            World  2019 Malaria - all types Diagnostics and diagnostic platforms
            World  2020 Malaria - all types Vector control products and research
    ~ Column amount__usd (changed metadata, new data)
-       - title: Funding for << product.lower() >>for treating << disease.lower() >>
+       + title: Funding for << product.lower() >> for treating << disease.lower() >>
        ?                                         +
+       + description_key:
+       +   - |-
+       +     This datset covers major funding towards Neglected Diseases: Bacterial pneumonia & meningitis, Buruli ulcer, Chagas disease, Cryptococcal meningitis, Dengue, Diarrhoeal diseases, Helminth infections (worms & flukes), Hepatitis B, Hepatitis C, Histoplasmosis, HIV/AIDS, Kinetoplastid diseases, Leprosy, Leptospirosis, Malaria, Mycetoma, Rheumatic fever, Salmonella infections, Scabies, Snakebite envenoming, Trachoma, Tuberculosis, Yaws. Emerging Infectious Diseases: Arenaviral haemorrhagic fevers (including Lassa fever), Bunyaviral diseases (including CCHF, RVF, SFTS), Chikungunya, Coronaviral diseases (including MERS, SARS, COVID-19), Emergent non-polio enteroviruses (including EV71, D68), Filoviral diseases (including Ebola, Marburg), Henipaviral diseases (including Nipah), Mpox (monkeypox), Zika. Sexual & Reproductive Health: Contraception, HIV/AIDS, HPV and HPV-related cervical cancer, Multi-purpose prevention technologies, Post-partum haemorrhage, Pre-eclampsia and eclampsia, Sexually transmitted infections.
-       -       The data collected in this survey has been used to create a unique repository of investment data, providing an unmatched resource for policy-makers, donors, researchers and industry. The database outlines the long-term landscape of funding for R&D for global health priority areas, including where funding gaps exist and how single investments fit into the global picture.
-       -     title_snapshot: G-FINDER -  Neglected Diseases
+       +       The data collected in this survey has been used to create a unique repository of investment data, providing an unmatched resource for policy-makers, donors, researchers and industry. The database outlines the long-term landscape of funding for R&D for global health priority areas, including where funding gaps exist and how single investments fit into the global picture. This dataset covers the majority of neglected disease, emerging infectious disease, and sexual & reproductive health R&D funding is captured by G-FINDER, because large funders active in this area and target groups identified by our Advisory Committee are typically responsive and, where they are not, are prioritised during survey follow-up.
+       + 
+       +       The dataset covers  major funding for: Neglected Diseases: Bacterial pneumonia & meningitis, Buruli ulcer, Chagas disease, Cryptococcal meningitis, Dengue, Diarrhoeal diseases, Helminth infections (worms & flukes), Hepatitis B, Hepatitis C, Histoplasmosis, HIV/AIDS, Kinetoplastid diseases, Leprosy, Leptospirosis, Malaria, Mycetoma, Rheumatic fever, Salmonella infections, Scabies, Snakebite envenoming, Trachoma, Tuberculosis, Yaws. Emerging Infectious Diseases: Arenaviral haemorrhagic fevers (including Lassa fever), Bunyaviral diseases (including CCHF, RVF, SFTS), Chikungunya, Coronaviral diseases (including MERS, SARS, COVID-19), Emergent non-polio enteroviruses (including EV71, D68), Filoviral diseases (including Ebola, Marburg), Henipaviral diseases (including Nipah), Mpox (monkeypox), Zika. Sexual & Reproductive Health: Contraception, HIV/AIDS, HPV and HPV-related cervical cancer, Multi-purpose prevention technologies, Post-partum haemorrhage, Pre-eclampsia and eclampsia, Sexually transmitted infections.
+       +     title_snapshot: G-FINDER

+       + New values: 101 / 3773 (2.68%)
          country  year             disease                              product  amount__usd
            World  2007 Malaria - all types                                Drugs  262052976.0
            World  2011 Malaria - all types                                Drugs  238387424.0
            World  2016 Malaria - all types Diagnostics and diagnostic platforms   22840514.0
            World  2019 Malaria - all types Diagnostics and diagnostic platforms   31259106.0
            World  2020 Malaria - all types Vector control products and research   72438472.0
+ + Table funding_product_ntd
+   + Column amount__usd


Legend: +New  ~Modified  -Removed  =Identical  Details
Hint: Run this locally with etl diff REMOTE data/ --include yourdataset --verbose --snippet

Automatically updated datasets matching weekly_wildfires|excess_mortality|covid|fluid|flunet|country_profile are not included

Edited: 2024-05-23 14:50:21 UTC
Execution time: 4.60 seconds